comprehensive -WSS

comprehensive

author：fashion 2025-09-07 00:19:49 - browse：89256

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： The inclusion problem at the heart of rehabilitation research

knowledge

WSS

Medicare bonuses could stop drug shortages under Senate plan

High breast density mammograms need follow

Virginia high school admissions case could be legal follow

Cardiologists urge adding sexual orientation, gender identity to health records

Future doctors need a strong humanities education

Medical leaders decry Supreme Court decision on affirmative action

leisure time

comprehensive

focus

Psychedelics group wrestles with new pharma identity

Duchenne breakthrough therapy leaves behind pioneering families

Activists slam private health insurers over coverage restrictions

Drug repurposing or repositioning? The language matters

Wildfire smoke exposes gaps in outdoor worker protections

HPV vaccine, cervical cancer study delivers historic results

Activists slam private health insurers over coverage restrictions

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

How one medical school became remarkably diverse

The inclusion problem at the heart of rehabilitation research

entertainment

Trump demands the U.S. pay no more for drugs than other countries … again

Flu vaccine reformulation won't be easy, manufacturers warn

New air purifier tech could be key to improving indoor air quality

The inclusion problem at the heart of rehabilitation research

High breast density mammograms need follow

Head of FDA's diagnostics center, who led through Covid, retires

knowledge

Wikipedia

focus

explore